Dr. Vijay Garg
Bone is often viewed simply as the framework that supports the body, but it is a living, dynamic tissue that constantly renews itself. Throughout life, old or damaged bone is removed by osteoclasts and new bone is produced by osteoblasts. With advancing age, however, this delicate balance gradually becomes disturbed. Bone loss, structural deterioration and reduced repair capacity can ultimately increase the risk of osteoporosis and fractures. Recent research describes bone aging not as a single process, but as a complex interaction of molecular, cellular, tissue and systemic changes.
How bones age
Bone remodeling is essential for maintaining skeletal strength. In younger individuals, bone formation and resorption remain relatively well coordinated. Aging can shift this balance toward greater resorption and reduced formation. Trabecular bone may become thinner and more disconnected, while cortical bone can become thinner and more porous. These structural changes reduce the ability of bone to withstand mechanical stress, even beyond what can be explained by bone mineral density alone.
At the cellular level, several populations are affected. Osteoblasts become less capable of producing new bone, while osteoclast activity can become relatively dominant. Osteocytes—the long-lived cells embedded within bone—also undergo age-related dysfunction. At the same time, skeletal stem and progenitor cells may lose regenerative potential and show a greater tendency toward fat-cell formation rather than bone-forming lineages.
Oxidative stress and mitochondrial dysfunction
One important mechanism of bone aging is the accumulation of cellular stress. Excess reactive oxygen species can damage DNA, proteins and cellular membranes. In bone-forming cells, excessive oxidative stress can impair differentiation and mineralization while promoting cellular dysfunction.
Mitochondria, the energy-producing structures of cells, also become less efficient with age. Disturbed mitochondrial quality control and impaired removal of damaged mitochondria can increase oxidative stress and contribute to cellular senescence. These changes can interfere with the high energy demands of bone formation and repair.
Cellular senescence: when aging cells become harmful
Cellular senescence is another important feature of skeletal aging. Senescent cells stop dividing but do not necessarily disappear. Instead, many release inflammatory molecules and other substances collectively known as the senescence-associated secretory phenotype (SASP).
In an aging bone microenvironment, these signals can promote inflammation and influence neighboring cells. Research indicates that senescent cells can impair osteoblast function while promoting conditions favorable to osteoclast activity. Experimental studies in mice have shown that removing senescent cells can reduce age-related bone loss, highlighting cellular senescence as a potential therapeutic target.
However, translating these findings into routine human treatment remains challenging. A 2024 phase 2 clinical trial of intermittent dasatinib plus quercetin in postmenopausal women did not show a significant difference in its primary bone-resorption endpoint, illustrating that promising laboratory findings do not automatically become effective clinical therapies.
Inflammation, hormones and the bone environment
Bone does not age in isolation. Chronic low-grade inflammation, changes in immune-cell behavior and alterations in the bone marrow environment can influence skeletal health. Aging is also accompanied by hormonal changes. The decline in estrogen around menopause, for example, can accelerate bone resorption, while age-related changes in male sex hormones can also affect skeletal maintenance.
Blood vessels and nerves within bone are also important. Bone formation and vascular development are closely connected, and age-related deterioration of specialized blood vessels can reduce support for bone-forming cells. Changes in neural signaling may further disturb bone remodeling.
Can aging bone be rejuvenated?
The concept of bone rejuvenation does not necessarily mean making old bone biologically identical to young bone. Rather, it involves restoring some of the mechanisms that maintain healthy skeletal remodeling.
Current approaches include established antiresorptive medicines that reduce excessive bone breakdown and anabolic treatments that stimulate bone formation. Lifestyle measures—including adequate nutrition, appropriate physical activity and avoidance of tobacco and excessive alcohol—also remain important components of skeletal health.
Research is now exploring more targeted strategies. These include senolytic therapies aimed at senescent cells, approaches targeting mitochondrial dysfunction and defective autophagy, regenerative medicine, tissue engineering and gene-based interventions. Researchers are also investigating how mechanical stimulation and cellular mechanosensing might rejuvenate aged skeletal stem cells. A 2026 study reported experimental evidence that mechanical stimulation can influence chromatin remodeling and the behavior of senescent stem cells in aged bone.
The road ahead
The future of bone-aging research is moving from treating bone loss as a single disease toward understanding it as a network of interacting processes. Genetics, epigenetics, inflammation, oxidative stress, cellular senescence, metabolism, vascular health and mechanical forces all contribute to the aging skeleton.
The recently published comprehensive review in Bone Research emphasizes the need for integrated approaches, including multi-omics maps of bone aging, bone organoids, computational models and precision therapies directed at specific aging pathways.
Bone aging is therefore not simply a matter of “getting older.” It is a biological process involving the gradual loss of cellular coordination and regenerative capacity. Understanding these mechanisms could eventually allow medicine to move beyond simply treating fractures and osteoporosis toward preserving skeletal health earlier and restoring aspects of bone function later in life.
Dr Vijay Garg Retired Principal Eminent Scientist street kour Chand MHR Malout Punjab -152107
